Roy A. Pleasants, PharmD

Pulmonary Division, The University of North Carolina at Chapel Hill, NC, USA;
Division of Pulmonary and Critical Care Medicine, Pulmonary Department, Durham VA Medical Center, NC, USA;

Roy Pleasants is a currently a Clinical Researcher with the Pulmonary Division at UNC Chapel Hill, Division of Pulmonary and Critical Care Medicine and with the Pulmonary Department at the Durham VA Medical Center. Dr Pleasants received his BS in Pharmacy from UNC-Chapel Hill and PharmD degree from the Medical University of South Carolina. He completed a 1 year residency at MUSC and has been practicing at academic centers as a tenure-track faculty member (University of North Carolina at Chapel Hill and Duke University) in adult pulmonary medicine and infectious diseases since 1985. 

 Dr Pleasants has been full-time faculty with the Medical University of South Carolina, University of North Carolina School of Pharmacy, Campbell University College of Pharmacy and Health Sciences, and the Duke University Pulmonary Division. 

 Dr Pleasants is currently President of the North Carolina Thoracic Society and past Co-Chair of the North Carolina COPD Taskforce. He is a member of two American Thoracic Committees (Clinicians Advisory Committee and Clinical Problems Assembly Program Committee). Dr Pleasants has been involved in public health efforts targeting COPD at state and national levels. He has worked with the CDC and NHLBI in their efforts to target COPD in the US. He was a coauthor of the 2017 National COPD Action Plan with the NIH and also led the development of two state COPD action plans. He is also involved in undertaking epidemiologic studies in interstitial lung diseases and obstructive sleep apnea in the US. His clinical research currently involves inhalational therapies, COPD, asthma, interstitial lung diseases, and clinical drug trials.

He is on the editorial board for Pulmonary Therapy, APHA DrugInfoline, and Intl J Lungs and Respiratory. He has Co-Chaired three journal supplements involving obstructive lung diseases. He has coauthored more than 100 manuscripts and book chapters.